Upgrade to SI Premium - Free Trial

Esperion Therapeutics (ESPR) Names Tracy M. Woody to Board

May 30, 2019 4:30 PM
Esperion (NASDAQ: ESPR) today announced the appointment of Tracy M. Woody as a Class I director, with a term expiring ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Changes Management Comments

Next Articles